Position in GMAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,790,732
+$22,388,282 QoQ
Shares Held
829,659
+5431.1% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#26
of 292 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. GMAB ranks #38 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in GMAB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,790,732 | 829,659 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $402,450 | 15,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $11,039,951 | 358,440 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $16,353,519 | 533,209 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $39,404,485 | 1,907,284 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $42,713,964 | 2,181,510 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $23,422,317 | 1,122,296 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $10,435,932 | 428,053 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $16,293,763 | 648,379 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $28,397,301 | 949,425 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $6,858,589 | 215,408 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $7,434,880 | 210,799 | Shares | Other | 2023-11-14 | |
| 2022-12-31 | $350,016 | 8,259 | Shares | Other | 2023-02-14 | |
| 2021-03-31 | $282,173 | 8,595 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,685,267 | 66,042 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,238,311 | 225,029 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $17,497,508 | 516,303 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,028,387 | 237,300 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||